Read the September 2019 issue of CFTN
The drug succinylcholine is renowned in modern medicine for its ability to provide short-term muscle paralysis to facilitate endotracheal intubation. Unfortunately, because of this unique property, it has also gained notoriety as a means to covertly commit homicide.
Four additional opioids (oxycodone, oxymorphone, hydrocodone, and hydromorphone) were added to the Department of Health and Human Services (HHS) Mandatory Guidelines for Federal Workplace Drug Testing Programs published on January 23, 2017, with an effective date of October 1, 2017.
On May 31, 2019, the FDA held its first ever public hearing on CBD, entitled “Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds.”
Contact the editors with any comments or questions.
